Publication Date:
2012-11-08
Description:
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses Leukemia 26, 2353 (November 2012). doi:10.1038/leu.2012.105 Authors: S K Metzelder, T Schroeder, A Finck, S Scholl, M Fey, K Götze, Y C Linn, M Kröger, A Reiter, H R Salih, T Heinicke, R Stuhlmann, L Müller, A Giagounidis, R G Meyer, W Brugger, M Vöhringer, P Dreger, M Mori, N Basara, K Schäfer-Eckart, B Schultheis, C Baldus, A Neubauer & A Burchert
Keywords:
AMLsorafenibFLT3-ITDstem cell transplantation
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink